Funding News for global health researchers from the Fogarty International Center at NIH

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Top NIH Funding News

NIH funding news that may be relevant to global health researchers:

Reminder: FORMS-G Grant Application Forms & Instructions Must be Used for Due Dates on or After January 25, 2022 - New Grant Application. Instructions Now Available. (NOT-OD-22-018)
Clarification and Guidance for Applicants Preparing Applications for the Spring 2022 Due Dates During the COVID-19 Pandemic(NOT-OD-22-046)
Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: August/October 2022 Councils(NOT-OD-22-047)

Upcoming Deadlines for Fogarty Funding Opportunities

International Research Scientist Development Award (IRSDA)
Application deadline: March 9, 2022
Chronic, Noncommunicable Diseases and Disorders Research Training
Application deadline: July 13, 2022
Upcoming deadlines for all Fogarty funding opportunities

Funding Opportunities

NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations, and/or foreign components may apply:

PBPK Modeling to Support an Assessment of Bioequivalence for Locally-Acting Drugs in the Gastrointestinal Tract (U01) Clinical Trial Optional (RFA-FD-22-012)
Application Receipt Date: March 31, 2022
Cutaneous Pharmacokinetics (PK) Based Approaches to Demonstrate Bioequivalence of Topical Products (U01) Clinical Trial Required (RFA-FD-22-017)
Application Receipt Date: March 31, 2022,
Research to support the development of alternatives to antimicrobials for use in food-producing animals (U01) Clinical Trial Not Allowed (PAR-22-087)
Application Receipt Date: April 1, 2022
Lipids in Brain Aging and Alzheimer's Disease (AD) and its Related Dementias (ADRD) (R01 Clinical Trial Not Allowed) (RFA-AG-23-009)
Application Receipt Date: June 14, 2022
Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) (RFA-MH-22-135)
Application Receipt Date: October 15, 2022
Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) (RFA-MH-22-136)
Application Receipt Date: October 15, 2022
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) (PAR-22-093)
Application Receipt Date: November 12, 2024
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional) (PAR-22-094)
Application Receipt Date: November 12, 2024

Other Funding News

NIH Notices of Special Interest (NOSIs) related to opportunities on which Fogarty is a funding partner:

Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) (NOT-OD-22-026)
Expiration Date: March 17, 2022
Availability of Administrative Supplements for Research on Pain, Pain Management, and Opioids in Aging (NOT-AG-22-005)
Expiration Date: April 29, 2022
Pain-Focused Administrative Supplements for NINDS Grants that are Not Focused on Pain Research (NOT-NS-22-053)
Expiration Date: June 2, 2022
NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp Clinical Trial Optional) (NOT-MH-22-060)
Expiration Date: April 2, 2024
NIDDK National Research Service Award (NRSA) T32 Diversity Administrative Supplement (NOT-DK-21-016)
Expiration Date: May 16, 2024
National Center for Complementary and Integrative Health (NCCIH) T32 Supplement Program for Pre- and Postdoctoral Candidates from Diverse Backgrounds (NOT-AT-21-013)
Expiration Date: July 2, 2024

NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers:

NINDS mission relevant Pain Research (NOT-NS-22-050)
Expiration Date: May 8, 2022
Migraine and Headache Research (NOT-NS-22-051)
Expiration Date: May 8, 2022
NCCIH High Priority Pain Research (NOT-AT-22-007)
Expiration Date: December 15, 2022
Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases (NOT-AR-22-012)
Expiration Date: January 8, 2023
Advancing Research Needed to Develop a Universal Influenza Vaccine (NOT-AI-22-013)
Expiration Date: January 8, 2025
Pediatric COVID-19 and Respiratory Viral Co-infection (NOT-HL-22-004)
Expiration Date: September 8, 2025
Advancing Innovative Non-invasive Physiologic Monitoring o Improve Fetal Assessment (NOT-HD-21-053)
Expiration Date: May 8, 2024

Notices of intent to publish NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations, and/or foreign components may apply:

HEAL Initiative: Advancing Health Equity in Pain and Comorbidities (R61/R33 Clinical Trial Required) (NOT-NS-22-040)
Estimated Publication Date: February 1, 2022
HEAL Initiative: Human Pain-associated Genes & Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed) (NOT-NS-22-063)
Estimated Publication Date: February 1, 2022
HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes & Cells (U19 Clinical Trial Not Allowed) (NOT-NS-22-065)
Estimated Publication Date: February 1, 2022
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed) (NOT-CA-22-027)
Estimated Publication Date: February 3, 2022
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed) (NOT-CA-22-026)
Estimated Publication Date: February 14, 2022
Biomedical-engineering Partnership with Industry (U01 Clinical Trial Not Allowed) (NOT-EB-21-024)
Estimated Publication Date: February 26, 2022

Non-NIH funding opportunities that may be of interest to global health researchers:

Call for proposals on infectious diseases (including antimicrobial resistance) and cancer research from e-ASIA Joint Research Program (the e-ASIA JRP).
Application deadline: March 30, 2022

Request for Information:

Request for Information (RFI): Inviting Comments and Suggestions on Updating the Strategic Plan for Trans-NIH Research to Cure Hepatitis B
(NOT-AI-22-018)

Featured Fogarty News and Information

Focus: Global cancer research supported by the National Cancer Institute (NCI)
View all Fogarty news
View and subscribe to Fogarty's Global Health Matters e-newsletter

Featured NIH News

Landmark COVID-19 vaccine trial in sub-Saharan Africa is the first to study the efficacy of MRNA COVID-19 vaccines in people living with HIV
HVTN/Fred Hutchinson Cancer Research Center news release, Dec 13, 2021

NIH COVID-19 Funding and News

Events

Training and events for global health researchers:

January 4, 2022: COVID: Then, Now, and the Future / The global challenge: COVID and Future Pandemics
Dr. Anthony Fauci, NIAID director, and Dr. Roger Glass, Fogarty director give this lecture, part of NIHs annual Demystifying Medicine course

More Information

STAY CONNECTED:

SUBSCRIBER SERVICES: Manage Preferences | Unsubscribe

You are subscribed to receive Fogarty Funding Opportunities email updates newsletter@newslettercollector.com.

The Fogarty International Center, the international component of the U.S. National Institutes of Health, addresses global health challenges through innovative and collaborative research and training programs and supports and advances the NIH mission through international partnerships. We encourage you to forward this to colleagues who may find it of interest.

This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud on behalf of: Fogarty International Center at NIH National Institutes of Health Bethesda, MD 20892 (301) 496-2075 ficinfo@mail.nih.gov